Landiolol hydrochloride exhibits ultra-short-acting pharmacokinetic properties with rapid steady-state achievement and dissipation.
No takes yet. Share an insight, caveat, or question.
Supports titratable beta-blockade with quick offset in acute care; confirms ultra-short-acting PK in this RCT.
Murakami et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: